Castelnau Group (CGL) Competitors GBX 79.50 0.00 (0.00%) As of 07/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock CGL vs. BPCR, AGT, BRWM, JPE, BBGI, TMPL, RICA, ICGT, CGT, and JEOShould you be buying Castelnau Group stock or one of its competitors? The main competitors of Castelnau Group include BioPharma Credit (BPCR), AVI Global Trust (AGT), BlackRock World Mining Trust (BRWM), JPMorgan Elect plc - Managed Growth (JPE), BBGI Global Infrastructure (BBGI), Temple Bar (TMPL), Ruffer Investment (RICA), ICG Enterprise Trust (ICGT), Capital Gearing (CGT), and European Opportunities Trust (JEO). These companies are all part of the "asset management" industry. Castelnau Group vs. Its Competitors BioPharma Credit AVI Global Trust BlackRock World Mining Trust JPMorgan Elect plc - Managed Growth BBGI Global Infrastructure Temple Bar Ruffer Investment ICG Enterprise Trust Capital Gearing European Opportunities Trust BioPharma Credit (LON:BPCR) and Castelnau Group (LON:CGL) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends. Which has more risk & volatility, BPCR or CGL? BioPharma Credit has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, Castelnau Group has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Which has better valuation & earnings, BPCR or CGL? BioPharma Credit has higher revenue and earnings than Castelnau Group. Castelnau Group is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioPharma Credit£12.99B0.08£10.42B£0.0910.00Castelnau Group£1.95M132.03£95.01M£29.272.72 Do insiders & institutionals hold more shares of BPCR or CGL? 41.5% of BioPharma Credit shares are held by institutional investors. Comparatively, 71.2% of Castelnau Group shares are held by institutional investors. 6.2% of BioPharma Credit shares are held by insiders. Comparatively, 4.7% of Castelnau Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer BPCR or CGL? In the previous week, BioPharma Credit's average media sentiment score of 0.00 equaled Castelnau Group'saverage media sentiment score. Company Overall Sentiment BioPharma Credit Neutral Castelnau Group Neutral Is BPCR or CGL more profitable? Castelnau Group has a net margin of 4,860.58% compared to BioPharma Credit's net margin of 80.20%. Castelnau Group's return on equity of 34.01% beat BioPharma Credit's return on equity.Company Net Margins Return on Equity Return on Assets BioPharma Credit80.20% 8.51% 4.98% Castelnau Group 4,860.58%34.01%-0.50% SummaryBioPharma Credit beats Castelnau Group on 6 of the 11 factors compared between the two stocks. Get Castelnau Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGL vs. The Competition Export to ExcelMetricCastelnau GroupAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£258.09M£1.25B£6.19B£2.96BDividend YieldN/A4.35%4.17%5.02%P/E Ratio2.7221.8113.27147.88Price / Sales132.032,406.261,777.10258,917.23Price / Cash7.4760.8149.7227.97Price / Book0.801.211.914.61Net Income£95.01M£264.68M£1.23B£5.90B7 Day Performance-1.73%0.37%0.57%1.04%1 Month Performance-3.38%2.46%3.00%4.36%1 Year Performance-20.10%6.26%15.69%82.36% Castelnau Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGLCastelnau GroupN/AGBX 79.50flatN/A-19.4%£258.09M£1.95M2.72N/AHigh Trading VolumeBPCRBioPharma CreditN/AGBX 0.88flatN/A+3.0%£1.04B£12.99B10.00N/APositive NewsAGTAVI Global TrustN/AGBX 238-0.6%N/A+1.5%£1.03B£219.59M4.78N/AHigh Trading VolumeBRWMBlackRock World Mining TrustN/AGBX 530+0.8%N/A-8.2%£1.01B£8.73M-75.82147,000JPEJPMorgan Elect plc - Managed GrowthN/AN/AN/AN/A£1.00B£104.78M1,250.00N/ABBGIBBGI Global InfrastructureN/AGBX 138.50flatN/AN/A£984.71M£67.98M17.931,160TMPLTemple BarN/AGBX 320+1.3%N/A+20.4%£915.46M£157.64M5.94N/ANews CoverageRICARuffer InvestmentN/AGBX 284-0.5%N/A+4.4%£913.84M£16.91M103.30N/AICGTICG Enterprise TrustN/AGBX 1,388+0.7%N/A+9.1%£897.04M£55.63M27.72N/APositive NewsCGTCapital GearingN/AGBX 4,785+0.3%N/A+1.4%£889.89M£17.92M19.45N/ANews CoverageJEOEuropean Opportunities TrustN/AN/AN/AN/A£886.70M-£62.33M-12.93N/A Related Companies and Tools Related Companies BioPharma Credit Alternatives AVI Global Trust Alternatives BlackRock World Mining Trust Alternatives JPMorgan Elect plc - Managed Growth Alternatives BBGI Global Infrastructure Alternatives Temple Bar Alternatives Ruffer Investment Alternatives ICG Enterprise Trust Alternatives Capital Gearing Alternatives European Opportunities Trust Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CGL) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castelnau Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Castelnau Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGL Stock Alerts